Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

BIMI International Medical Inc. (BIMI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7100-0.0719 (-9.20%)
At close: 04:00PM EST
0.7075 -0.00 (-0.35%)
After hours: 07:57PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close0.7819
Open0.7500
Bid0.7100 x 1200
Ask0.7200 x 1400
Day's Range0.7000 - 0.7829
52 Week Range0.5300 - 2.8100
Volume1,564,816
Avg. Volume9,318,139
Market Cap25.962M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for BIMI

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BIMI International Medical Inc.
    DOV: Raising target price to $185.00DOVER CORP has an Investment Rating of HOLD; a target price of $185.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    11 days agoArgus Research
View more
  • GlobeNewswire

    BIMI International Medical Inc. Announces Pricing of $7.8 million Private Placement

    New York, Nov. 18, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced that it has entered into a Securities Purchase Agreement (the “SPA”) with two institutional investors (the “Holders”) to sell certain senior secured convertible notes of the Company in a private placement in the aggregate principal amount of $7,800,000 in the aggregate original principal amount of $6,500,000, representi

  • GlobeNewswire

    BIMI International Medical Inc. Announces Third Quarter 2021 Financial Results

    NEW YORK, Nov. 15, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a leading healthcare products and services provider, today announced its unaudited financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Highlights: Revenues. Revenues for the three months ended September 30, 2021 increased to $13,777,494 from $3,091,071 in the comparable period in 2020, an increase of $10,686,423, or 345.7%. Gross profit. Gross pro

  • GlobeNewswire

    BIMI International Medical Inc. Announces Results of Special Meeting

    NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a leading healthcare products and services provider, today announced that shareholders have approved the two proposals voted on at the Registrant’s special meeting of shareholders held on November 5, 2021. The first proposal is an amendment to the Registrant’s Certificate of Incorporation to increase the number of Registrant’s authorized shares of common stock (the “Common Stock”

Advertisement
Advertisement